AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwon, O-K.
Right arrow Articles by Koh, Y. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwon, O-K.
Right arrow Articles by Koh, Y. C.

Intraarterially Administered Abciximab as an Adjuvant Thrombolytic Therapy: Report of Three Cases

O-Ki Kwona, Ki Jae Leea, Moon Hee Hanb,d, Chang-Wan Ohc, Dae Hee Hanc and Young Cho Koha

a Neurovascular Center, Inje University, Seoul Paik Hospital, Seoul, Korea
b Departments of Radiology Seoul National University College of Medicine, Clinical Research Institute, Seoul, Korea
c Departments of Neurosurgery, Seoul National University College of Medicine, Clinical Research Institute, Seoul, Korea
d Seoul National University Hospital, Seoul, Korea



View larger version (89K):

[in a new window]
 
FIG 1. Case 1. Angiograms show an acute middle cerebral artery occlusion treated with intraarterially administered urokinase and abciximab.

A, Initial angiogram shows occlusion of the left M1 segment.

B, After the intraarterial infusion of urokinase (100,000 U), the artery is partially opened.

C, Angiogram obtained after the intraarterial infusion of urokinase (300,000 U) shows aggravation of thrombotic occlusion of the M1 segment.

D, Angiogram obtained 5 minutes after intraarterial infusion of 10 mg of abciximab shows a partial recanalization. Remaining thrombi are seen within the superior division of the middle cerebral artery.

E, Angiogram obtained another 5 minutes later shows more advanced recanalization.

F, Final angiogram shows further recanalization. Although one branch of the inferior division of the middle cerebral artery is still occluded, in lateral projection, there was no missing artery owing to well-developed collaterals (not shown).



View larger version (47K):

[in a new window]
 
FIG 2. Case 2. Angiograms show a thrombotic complication that occurred during embolization with Guglielmi detachable coils; this was successfully treated with intraarterial abciximab.

A, Angiogram shows a bilobulated posterior communicating artery aneurysm.

B, Angiogram obtained after detachment of the last coil shows thrombotic occlusion of the parent artery.

C, Angiogram obtained 5 minutes after intraarterial infusion of abciximab (5 mg) through a guide catheter shows recanalization, although there remains a luminal narrowing of the parent artery due to the protruding coil mass.



View larger version (48K):

[in a new window]
 
FIG 3. Case 3. Angiograms show a thrombotic complication that occurred during embolization with Guglielmi detachable coils; this was successfully treated with intraarterially administered abciximab.

A, Initial angiogram shows an anterior communicating artery aneurysm.

B, Angiogram obtained after complete occlusion with five Guglielmi detachable coils shows luminal narrowings of both A2 segments.

C, Angiogram obtained 15 minutes after intraarterial infusion of abciximab (4 mg) by means of a microcatheter shows an obvious thrombolysis. Bloodflow through the right A2 segment is completely restored.